Barely Significant
← all excerpts

The role of taxanes in triple-negative breast cancer: literature review.

Drug Des Devel Ther · 2015 · PMC4532347 · PMID 26273192

Europe PMCDOI
3
hedged sentences
0.0030
closest p · 0.1× alpha
0.0030
boldest claim

The sentences

highly significantP =0.003actually significant
Among the 663 patients with TNBC, pCR rates were 39.3% with bevacizumab vs 27.9% in controls, and the difference was highly significant (odds ratio [OR] 1.67, 95% CI 1.21–2.31, P =0.003).

also in 132,142 other papers

did not reach statistical significanceno p-value reported
According to the independent radiologist review, both schedules of 150 mg/m 2 (49%) and 100 mg/m 2 (45%) weekly of nab-paclitaxel demonstrated a higher ORR vs docetaxel (35%), but this did not reach statistical significance.

also in 111,027 other papers

a nonsignificant trendno p-value reported
In patients with wild-type BRCA1/2 , there was a nonsignificant trend for a higher response rate with docetaxel.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.